30.07.2007 12:00:00
|
Millennium Cell Reports Second Quarter Results
Millennium Cell Inc. (NASDAQ: MCEL), a leading developer of hydrogen
battery technology today reported a net loss for the quarter ended June
30, 2007 of $2.7 million, or $0.05 per share, as compared to $4.7
million, or $0.10 per share in the same period of 2006. Total revenue
and cost reimbursements were approximately $566,000 for the second
quarter of 2007, up from $373,000 in the same quarter in the prior year.
On a year-to-date basis, total revenue and cost reimbursements were
approximately $1.0 million, up from $0.7 million in the same period of
2006. The increase in revenues and cost reimbursements is due to a
larger number of funded contracts with the U.S. Air Force in 2007 than
in the prior year.
Total operating expenses on a year-to-date basis declined from 2006
levels due to a non-cash charge of $2.1 million related to preferred
stock that was issued to The Dow Chemical Company during the second
quarter of 2006. On a year-to-date basis, cash used in operating
activities was $3.9 million in 2007 as compared to $4.1 million in the
same period of 2006.
"We continue to pursue the commercialization
of our hydrogen battery technology with our various licensees,”
stated H. David Ramm, Millennium Cell Chief Executive Officer. "During
the quarter, products which use our technology for soldier power
continue to be tested by the military. We also announced that Protonex
Technology Corporation (LSE: PTX
- News), a licensee
of Millennium Cell's Hydrogen on Demand®
technology, provided the fuel cell system that powered the flight of
AeroVironment's (NASDAQ: AVAV
- News) "Puma”
small unmanned aircraft system (UAS) for nearly five hours, which
significantly exceeded the flight record for this small UAV. We are very
pleased to communicate these accomplishments.” "Earlier this week we announced the completion
of Milestone 2 under our joint development agreement with The Dow
Chemical Company ("Dow”).
Through our collaboration, we have been able to advance the development
of our hydrogen battery technology which has resulted in the delivery of
fuel cell powered products to the U.S. Air Force for testing and
evaluation by our licensee Protonex Technology Corporation. This
delivery marked the achievement of Milestone 2. With Dow, we are
developing Solid State HOD™ technology, an
innovative approach to hydrogen storage which offers unlimited shelf
life, no moving parts and a significant extension of the runtime of fuel
cell powered consumer electronic devices. The final phase of our
agreement with Dow will focus on this technology which will
significantly enhance our ability to address the consumer marketplace.” "As a result of the milestone achievement,
Dow will receive shares of the Company’s
Series A Preferred Stock within 70 days of June 30, 2007. The amount of
securities that Dow will receive will be based on the volume weighted
average trading price of Millennium Cell’s
common stock for the 30 days prior to issuance in accordance with the
agreements. For more details, please refer to the Company's Form 8-K
filed on July 26, 2007 with the Securities and Exchange Commission,”
concluded Mr. Ramm.
The Company will host a conference call on July 30, 2007 at 10:30 a.m.,
EST to discuss its first quarter results. Interested parties may listen
to the live teleconference by dialing 1-877-317-6701 and entering
passcode 9635343. A telephonic replay of the conference call will also
be available through August 10, 2007, by calling 1-877-344-7529 and
entering passcode 9635343.
To listen to a live broadcast of the call over the Internet or to review
the archived call, please visit: www.millenniumcell.com
under the "Investor Relations" section.
About Millennium Cell
Millennium Cell is a leader in the development of hydrogen battery
technology used to power portable applications. Through its proprietary
Hydrogen on Demand® fuel cartridges and
PowerSkin™ fuel cell modules, the Company
provides increased energy density resulting in longer runtime and
lighter weight in a compact space. The Company is working with market
partners to meet the demand for a better battery in the military,
medical, industrial and consumer electronics markets. For more
information, visit www.millenniumcell.com.
Cautionary Note Regarding Forward-looking Statements:
This press release may include statements that are not historical facts
and are considered ``forward-looking" within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements reflect Millennium Cell's current views about future events
and financial performance and are subject to risks. Forward-looking
statements are identified by their use of terms and phrases such as
"believe," "expect," "plan," "anticipate," "on target" and similar
expressions identifying forward-looking statements. Investors should not
rely on forward-looking statements because they are subject to a variety
of risks, uncertainties and other factors, many of which are outside of
our control, that could cause actual results to differ materially from
Millennium Cell's expectations, and Millennium Cell expressly does not
undertake any duty to update forward-looking statements. These factors
include, but are not limited to, the following: (i) the cost and timing
of development and market acceptance of Millennium Cell's hydrogen fuel
storage and delivery system; (ii) the cost and commercial availability
of the quantities of raw materials required by the hydrogen fuel storage
and delivery systems; (iii) competition from current, improving and
alternative power technologies; (iv) Millennium Cell's ability to raise
capital at the times, in the amounts and at the costs and terms that are
acceptable to fund the development and commercialization of its hydrogen
fuel storage and delivery system and its business plan; (v) Millennium
Cell's ability to protect its intellectual property; (vi) Millennium
Cell's ability to achieve budgeted revenue and expense amounts; (vii)
Millennium Cell's ability to generate revenues from the sale or license
of, or provision of services related to, its technology; (viii)
Millennium Cell's ability to form strategic alliances or partnerships to
help promote our technology and achieve market acceptance; (ix)
Millennium Cell's ability to generate design, engineering or management
services revenue opportunities in the hydrogen generation or fuel cell
markets; (x) Millennium Cell's ability to secure government funding of
its research and development and technology demonstration projects; and
(xi) other factors discussed under the caption "Investment
Considerations" in Millennium Cell's Annual Report on Form 10-K for the
year ended December 31, 2006.
Millennium Cell Inc.(a development stage enterprise)(dollars
in millions, except per share amounts)
Three Months Ended Six Months Ended Statement of Operations (1)
Jun.,07 Jun.,06 Jun.,07 Jun.,06
Revenue
$
-
$
-
$
0.1
$
0.1
Cost of revenue
-
-
0.1
0.1
Gross margin
-
-
-
-
Product development and marketing, net
1.1
0.8
2.1
1.7
General and administrative, net
0.9
1.0
1.7
2.1
Non-cash charges
0.3
2.5
0.5
2.7
Depreciation and amortization
0.2
0.1
0.4
0.2
Research and development, net
0.2
-
0.3
0.2
Total operating expenses
2.7
4.4
5.0
6.9
Loss from operations (2.7 ) (4.4 ) (5.0 ) (6.9 )
Interest expense
-
0.3
0.3
0.5
Net loss $ (2.7 ) $ (4.7 ) $ (5.3 ) $ (7.4 )
Net loss per share $ (0.05 ) $ (0.10 ) $ (0.10 ) $ (0.16 )
Weighted-average number of shares outstanding
54.9
48.4
54.0
47.7
(1) The 2007 results of operations include the impact of the
acquisition of Gecko Energy Technologies, which was completed on
December 29, 2006. Prior to the acquisition, the results include
Millennium Cell's proportionate share of the losses of Gecko
according to the equity method of accounting since the initial
investment on February 15, 2006. Millennium Cell Inc.(a development stage enterprise)(dollars
in millions)
Condensed Balance Sheet Jun., 07 Dec., 06
Unrestricted cash (1)
$
6.2
$
4.4
Restricted cash (2)
0.8
1.0
Accounts receivable
0.6
0.6
Fixed assets, net
0.2
0.2
Intangibles, net
3.1
3.3
Other assets
0.4
0.5
Total assets $ 11.3 $ 10.0
Accounts payable and accrued expenses
$
1.6
$
1.4
Unsecured debentures, net of discount
5.6
0.4
Preferred Stock - Series C, net of discount
2.0
4.7
Other liabilities
0.6
0.4
Stockholders' equity
1.5
3.1
Total liabilities and stockholders' equity $ 11.3 $ 10.0
(1) Increase in cash from $4.4 (Dec.,06) to $6.2 (June,07) was
$1.8 million: ($3.9) consumed in operations + $5.7 cash provided
by financing activiites
(2) Cash restricted is collateral for Series C Preferred Stock
($0.2) and facility lease ($0.6).
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Millennium Cell Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Millennium Cell Inc.mehr Analysen
Aktien in diesem Artikel
Millennium Cell Inc. | 0,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 218,17 | 0,83% |